LOUGHBOROUGH, England--(BUSINESS WIRE)-- Nemaura Medical, Inc. (NASDAQ:NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT®, its non-invasive and flexible continuous glucose monitor (“CGM”), together with BEAT™diabetes, a planned health subscription service designed to help people with Type 2 diabetes and prediabetes through personalized lifestyle coaching, today announced an interview with its CEO Dr. Faz Chowdhury will air on The RedChip Money Report television program. The interview will air Sunday, June 28, at 3 p.m. local time on Bloomberg International, available in 100+ million homes across Europe.
In the exclusive interview, Dr. Chowdhury provides insight into the Company’s product rollout strategy, including early results from previously announced head-to-head studies with competitor CGMs.
To view the interview segment, please visit: https://youtu.be/7Mujq9_wDOw
The interview will also air in the US on the Action Channel on Sunday June 28 at 11 a.m. and is available via live stream on American Business TV.
“The RedChip Money Report" delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies.